Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
NYSE:ZYME
Price:
9.15 USD
1.67%
Market Closed
Updated:
May 16, 2024
Zymeworks Inc
EPS (Diluted)
|
Zymeworks Inc
EPS (Diluted) Peer Comparison
Comparables:
TH
RPTX
FUSN
AUPH
EDT
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Zymeworks Inc
NYSE:ZYME
|
EPS (Diluted)
-$1
|
CAGR 3-Years
22%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Theratechnologies Inc
TSX:TH
|
EPS (Diluted)
$0
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
-10%
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
EPS (Diluted)
-$2
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
EPS (Diluted)
-$1
|
CAGR 3-Years
9%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
EPS (Diluted)
$0
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
|
Spectral Medical Inc
TSX:EDT
|
EPS (Diluted)
CA$0
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-43%
|
CAGR 10-Years
4%
|
See Also
What is Zymeworks Inc's EPS (Diluted)?
EPS (Diluted)
-1.7
USD
-1.7
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's EPS (Diluted) amounts to -1.7 USD.
What is Zymeworks Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-6%
-6%
The average annual EPS (Diluted) growth rates for Zymeworks Inc have been 22% over the past three years , -6% over the past five years .
You don't have any saved screeners yet
